Fibrates but not statins increase plasma selenium in dyslipidemic aged patients – The EVA study
- 31 January 2009
- journal article
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 23 (1) , 21-28
- https://doi.org/10.1016/j.jtemb.2008.08.001
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Neurological Recovery-Promoting, Anti-Inflammatory, and Anti-Oxidative Effects Afforded by Fenofibrate, a PPAR Alpha Agonist, in Traumatic Brain InjuryJournal of Neurotrauma, 2007
- Lipid-lowering drugsCellular and Molecular Life Sciences, 2006
- Low Serum Selenium and Total Carotenoids Predict Mortality among Older Women Living in the Community: The Women's Health and Aging StudiesJournal of Nutrition, 2006
- Selenium and Mortality in the Elderly: Results from the EVA StudyClinical Chemistry, 2005
- Selenium in cancer prevention: a review of the evidence and mechanism of actionProceedings of the Nutrition Society, 2005
- Selenoproteins, Cholesterol-Lowering Drugs, and the Consequences Revisiting of the Mevalonate PathwayTrends in Cardiovascular Medicine, 2004
- Assessment of requirements for selenium and adequacy of selenium status: a reviewEuropean Journal of Clinical Nutrition, 2004
- Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart DiseaseDrugs, 2004
- Selenium status and its correlates in a British National Diet and Nutrition Survey: people aged 65 years and overJournal of Trace Elements in Medicine and Biology, 2002
- Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish menAtherosclerosis, 1988